Kemira's stock struggles amid weak chemical sector demand and falling prices
Finnish chemicals company Kemira Oyj has faced a difficult year on the stock market. Its share price dropped 2.18% to €18.38 on Nasdaq Helsinki, reflecting broader weakness in the OMX Helsinki 25 index. The decline comes amid ongoing challenges in the chemical sector, where falling raw material prices and weak industrial demand have weighed on performance.
Over the past 12 months, funds holding Kemira have seen losses between -7.03% and -10.85%, suggesting the stock has underperformed the Helsinki benchmark. Despite this, the company remains a key player in specialty chemicals, with a focus on water treatment and paper chemicals—areas less exposed to market swings than commodity chemical producers.
Kemira's current share price hovers between €19.70 and €19.82, with neutral short-term momentum. The company trades at a price-to-earnings (P/E) ratio of around 12, below the industry average. This positions it as a classic value stock, appealing to investors seeking long-term stability and dividend income.
The firm offers a steady dividend yield of about 4%, making it particularly attractive in the DACH region (Germany, Austria, and Switzerland). Analysts expect this reliability to continue, forecasting stable earnings and gradually rising dividends in the coming years.
Beyond its financial resilience, Kemira is investing in green chemicals and circular economy solutions. As demand for sustainable water treatment grows, the company is positioning itself for future growth. Industry experts believe its share price could recover once market conditions stabilise. The next quarterly earnings report, due on October 24, will provide further clarity on its trajectory.
Kemira's share price has struggled alongside broader sector weaknesses, but its strong position in specialty chemicals and sustainable solutions offers long-term potential. With a stable dividend and a low P/E ratio, the company remains a defensive choice for investors. The upcoming earnings report will be closely watched for signs of improvement.